| Document |
Document Title |
|
WO/2007/062059A1 |
The present invention provides a fluorinated surfactant having the general formula [Rf(O)t-CQH-CF2-O]n-R-G, wherein Rf represents a partially or fully fluorinated aliphatic group optionally interrupted with one or more oxygen atoms, Q is...
|
|
WO/2007/057228A1 |
A process for making montelukast, a pharmaceutically useful compound of the following formula and salts and derivatives thereof: using a compound of formula (5b) is provided.
|
|
WO/2007/055212A1 |
The object is to provide a process for production of a compound having a fluorosulfonyl group and a novel compound. Thus, disclosed is a process for producing any one selected from the compounds (11) to (14) shown below. The process comp...
|
|
WO/2007/052831A1 |
A compound represented by the formula (I): wherein Ar represents a group represented by the formula: (wherein Y represents methylene or an oxygen atom, R1 represents aminosulfonyl, C1-6 alkylaminosulfonyl, C1-6 alkylcarbonylamino or C1-6...
|
|
WO/2007/049631A1 |
Disclosed is a charge-transporting varnish containing a charge-transporting organic material, a good solvent, at least one poor solvent with high leveling properties, and at lest one volatile poor solvent. The charge-transporting organic...
|
|
WO/2007/049613A1 |
A process for trifluoromethanesulfonic anhydride production which comprises a step in which trifluoromethanesulfonic acid is reacted with phosphorus pentoxide to yield trifluoromethanesulfonic anhydride, wherein the trifluoromethanesulfo...
|
|
WO/2007/046442A1 |
A compound that exhibits high absorption in the long wavelength region of 365 nm or greater and exhibits high sensitivity in the long wavelength region of 365 nm or greater, excelling in solubility in organic solvents; an acid generator ...
|
|
WO/2007/042313A2 |
The invention relates to a method for efficiently and safely producing organic peroxides, preferably dialkyl peroxides, peroxycarboxylic acids, peroxycarboxylic esters, diacyl peroxides, peroxycarbonate esters, peroxydicarbonates, ketone...
|
|
WO/2007/037466A1 |
To provide: a hydrophilized polyalkylene glycol which is preferably used in various applications, and sufficiently exhibits high performances such as detergency; a production method thereof; and an application thereof. A hydrophilized po...
|
|
WO/2007/038116A1 |
The present invention comprises a novel multi-step process to a specific amino acid derivative (1) from (4-hydroxymethyl)benzaldehyde including the key steps of: (i) asymmetric hydrogenation, thereby avoiding yield losses associated with...
|
|
WO/2007/037411A1 |
A process for the production of potassium perfluoroalkane- sulfonates which comprises the electrolytic fluorination step of electrofluorinating an alkanesulfonyl halide in anhydrous hydrofluoric acid to obtain a gas containing a perfluor...
|
|
WO/2007/032498A1 |
A process for producing an intermediate of a compound which shows an effect of inhibiting activated blood coagulation factor Xa and, therefore, is useful as a preventive and a remedy for thrombotic diseases. Namely, a process for produci...
|
|
WO/2007/029883A1 |
Disclosed is a process for production of an optically active α-substituted mandelic acid compound (a compound useful as an intermediate for synthesis of a pharmaceutical or the like) in an industrially advantageous manner. The process c...
|
|
WO/2007/029442A1 |
An adamantane derivative useful as a monomer for functional resins such as photosensitive resins in the field of photolithography. The adamantane derivative has a structure represented by the general formula (I) or (IV). In the formulae,...
|
|
WO/2007/026374A1 |
The present invention provides a single pot process for the preparation of diazonaphthoquinonesulfonyl ester, a useful organic material for micro electronic and dye industry. This study pertains to the one pot preparation of diazonaphtho...
|
|
WO/2007/017639A1 |
Disulfonate salts of 2,4-pentanedione and methods for making such salts are described. The disulfonate salts are useful as cement dispersants. Cement compositions including such salts, methods for making cement compositions including suc...
|
|
WO/2007/013533A1 |
Disclosed is a solid polymer electrolyte material for solid polymer fuel cells which has high ion exchange capacity and low resistance. This electrolyte material has a higher softening temperature than the conventional electrolyte materi...
|
|
WO/2007/013532A1 |
A compound containing two fluorosulfonyl groups, which are groups convertible to sulfo groups; an intermediate therefor; and processes for producing these compounds with high productivity. Also provided are: a fluorosulfonylated polymer ...
|
|
WO/2007/011293A1 |
The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) mediated d...
|
|
WO/2007/006300A1 |
The invention relates to producing monomer, oligomer and polymer non-fluorinated, partially fluorinated or perfluorinated sulphonic acids by reacting halogenated, low-molecular weight, oligomer or macromolecular arenes with (hydrogen) su...
|
|
WO/2007/005430A1 |
The present application provides a process to produce fluorinated vinyl ether by reacting a 2-alkoxypropionyl fluoride with a metal carbonate under anhydrous conditions in a stirred bed reactor at a temperature above the decarboxylation ...
|
|
WO/2006/137473A1 |
A process for producing an aromatic sulfonic acid compound, comprising sulfonating a compound having at least one aromatic ring with the use of any of compounds of the formula (1) as a sulfonating agent. This provides a process for produ...
|
|
WO/2006/136919A1 |
The present invention relates to a method for the preparation of Florfenicol from Fluoroamine compound, namely (1R,2S)-1-[4-(methylsulfonyl)phenyl]-2-amino-3-fluoro-1-prop
anol (II), by reaction with dihaloacetic acid ester in an organic...
|
|
WO/2006/137774A1 |
There is provided a process for the preparation of a compound of formula I, which process comprises: (a) reaction of a compound of formula II, HO-D-NH2 II with a compound of formula III, followed by (b) reaction of the intermediate of fo...
|
|
WO/2006/137376A1 |
Disclosed is a compound having high pesticidal effects which is represented by the general formula (1) below. Also disclosed is a pesticide containing such a compound as an active ingredient. (1) (In the formula, A1, A2, A3 and A4 respec...
|
|
WO/2006/133330A1 |
Hydrofluoroalkanesulfonates of the general formula R-O-CXH-CX2-SO3M, where R is selected from the group consisting of alkyl groups, functionalized alkyl groups, and alkenyl groups; X is selected from the group consisting of hydrogen and ...
|
|
WO/2006/133331A1 |
A process for manufacture of hydrofluoroalkanesulfonic acid with at least one hydrogen bonded to the carbon atom adjacent to the carbon atom bonded to the sulfonic acid group comprising: contacting a fluoroolefin with sulfite in an aqueo...
|
|
WO/2006/120574A2 |
The invention relates to analogs of 4-hydroxyisoleucine, and to lactones, pharmaceutically acceptable salts, and prodrugs thereof, to processes for their preparation, and to pharmaceutical compositions comprising the same. The analogs of...
|
|
WO/2006/121390A2 |
Compounds of formula I, wherein Y = H, -OH, halo, -OC1-6alkyl, -C1-6alkyl, the two latter optionally substituted with halo, -CN, -OH, -CF3, -NH2; Rl = -C3-6cycloaUcyl, heterocycloalkyl, aryl, alkylaryl, heteroaryl, -C3-6-alkyl, optionall...
|
|
WO/2006/120816A1 |
A process in which a functional molecule capable of ionic dissociation which is stable not only chemically but also thermally under operating conditions required for electrochemical apparatus, such as fuel cells, being suitable for use a...
|
|
WO/2006/121096A1 |
Disclosed is a radiation-sensitive resin composition which is highly transparent to radiation while being excellent in basic physical properties of a resist such as sensitivity, resolution and pattern shape. This radiation-sensitive resi...
|
|
WO/2006/114264A1 |
The invention provides compounds of formula (I), wherein the substituents are as defined in the specification, to processes for their preparation and their use as pharmaceuticals.
|
|
WO/2006/109570A1 |
Disclosed is a method for commercially advantageously producing 2-isopropenyl-5-methyl-4-hexen-1-yl 3-methyl-2-butenoate with high yield. Specifically disclosed is a method for producing 2-isopropenyl-5-methyl-4-hexen-1-yl 3-methyl-2-but...
|
|
WO/2006/108883A1 |
The present invention relates to a method for preparing a highly soluble linear alkyl benzene sulphonate (LAS). Specifically, the method includes adding a hydrotropic composition before or after the sulphonation of the linear alkyl benze...
|
|
WO/2006/106960A1 |
A disulfonyl fluoride compound is easily and efficiently produced through a coupling reaction. The compound is converted to produce a useful compound. A compound (1) in which Y is fluorine is subjected to a photocoupling reaction, while ...
|
|
WO/2006/100225A2 |
Benzoic acid ester compounds of formula (I) wherein R and R1-R5 have the meanings explained in the description, methods for producing them and use thereof in cosmetic, pharmaceutical, personal care and industrial preparations as sunscree...
|
|
WO/2006/088317A1 |
The present invention relates to a novel compound with a fluoroalkylsulfonium photoacid generating group and novel copolymers having superior solubility in organic solvents, which is prepared from radical polymerization of the novel comp...
|
|
WO/2006/087222A1 |
The present invention relates to a process for the preparation of compounds of formula (I) wherein the substituents are as defined in claim 1 , by a) reaction of a compound of formula (II) wherein the substituents are as defined in claim...
|
|
WO/2006/087221A1 |
The present invention relates to a process for the preparation of compounds of formula (I) wherein the substituents are as defined in claim 1, by reaction of a compound of formula (II) wherein the substituents are as defined in claim 1, ...
|
|
WO/2006/087166A1 |
Provided is a process for the preparation of N-monosubstituted β-aminoalcohol sulfonates of formula (Ia), (Ib) wherein R1 is C6-20 aryl or C4-12 heteroaryl, each optionally being substituted with one or more halogen atoms and/or one or ...
|
|
WO/2006/085149A2 |
Compounds of formulae (VIII), (IX), (X), (XI), (XII) (XIII), (XIV) and (XV), in which the variables are as defined in the claims are described, as well as methods, pharmaceutical compositions and kits for treating or preventing amyloid-r...
|
|
WO/2006/084262A1 |
The present invention relates to an absorption cycle comprising a refrigerant pair comprising at least one refrigerant and at least one ionic liquid. The present invention also provides an absorption cycle that utilizes fluorocarbon gase...
|
|
WO/2006/082511A1 |
This invention relates to a novel salt form of dopamine agonist 5-[(2R,5S)-5-methyl-4propylmorpholin-2-yl]pyridin-2-amine (I): More particularly, this invention relates to 5-[(2R,5S)-5-methyl-4-propylmorpholin-2yl]pyridin-2-amine di-...
|
|
WO/2006/080574A1 |
It is intended to provide a drug which is efficacious against pathological conditions relating to arginine-vasopressin V1b receptor. More particularly speaking, it is intended to provide a drug which has a therapeutic or preventive effec...
|
|
WO/2006/066931A1 |
A new process for preparation of 3-(2-hydroxy-5-methylphenyl)-N,N-diisopropyl-3-phenylpropyla
mine from 3,4-dihydro-6-methyl-4-phenyl-2-benzopyran-2-one is characterized by intermediates such as 3-(2-hydroxy-5-methyl phenyl)-3- phenylpro...
|
|
WO/2006/062563A1 |
Disclosed herein is a method for inhibiting and retarding the premature polymerization and the polymer growth of vinyl aromatic monomers wherein the method comprises adding to said monomers an effective amount of an inhibitor and retarde...
|
|
WO/2006/061549A1 |
A process for producing tamsulosin of formula (I) and pharmaceutically acceptable addition salts, thereof comprises the steps of : a) Reacting compound R,R-[2-(4-methoxy-phenyl)-1-methyl-ethyl]-(1-phenyl-ethyl)-a
mine of formula (II) or ...
|
|
WO/2006/059252A2 |
Methods, compounds, pharmaceutical compositions and kits are described for treating or preventing amyloid-related disease. Also described are methods, compounds, pharmaceutical compositions and kits for detecting, diagnosing, monitoring ...
|
|
WO/2006/051697A1 |
Disclosed is a method for producing a fluorine-containing fluorosulfonyl alkylvinyl ether represented by the following chemical formula: CF2=CFOCF2CF2SO2F which is characterized in that a fluorine-containing chlorosulfonyl alkylvinyl eth...
|
|
WO/2006/052522A2 |
Disclosed are methods for making the phosphonium sulfonate salt of generic formula: (1): wherein each X is independently a halogen or hydrogen, provided that the molar ratio of halogen to hydrogen is greater than about 0.90; p is 0 or 1 ...
|
